十一月 2025
- Home
- NextPharma
十一月 2025的NextPharma市场份额分析
At NextPharma, we are committed to providing outstanding value to our customers for their health products development. NextPharma's core strength is our leadership in the nutrition business.
NextPharma(包含公司地区分支机构)
查看更多网站流量和参与度信息- nextpharma.com
NextPharma收入截至 十一月 2025为 200M - 500M
NextPharma主要域名产生的收入
3 年中NextPharma主要域名的收入
NextPharma主要域名的收入
NextPharma热门域名的总访问量
了解NextPharma市场份额和潜在市场覆盖范围。
过去 3 个月的总访问量
子公司明细
NextPharma热门域名的平均访问时长
分析NextPharma参与度指标。
过去 3 个月的平均访问时长
子公司明细
NextPharma热门域名的平均页面浏览量
了解NextPharma如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。
过去 3 个月的平均页面浏览量
子公司明细
想要获取更深入的流量洞见?
过滤超过 2030 万家在线企业。发现流量激增的新潜在客户,开始或停止使用技术的新潜在客户,或者获得正面报道的新潜在客户。
NextPharma 的新闻与信号
借助 Similarweb 销售信号提醒,每当在目标受众之中出现新的机会或威胁时,您都会收到所识别出购买信号的每日更新。
新闻Nextpharma Technologies USA Inc hired Ajeeth Enjeti as CEO on Jan 1st '14.NextPharma announced the appointment of Ajeeth Enjeti as CEO, succeeding Peter Burema, who has led the company since 2014.
十月 7, 2025阅读更多
新闻Nextpharma Technologies USA Inc expanded facilities to Tampere, Finland on Jan 1st '19.“NextPharma continues to build out its technological platforms, expertise and capacities and our 2019 acquisition of the ophthalmic manufacturing facility in Tampere, Finland, with capabilities to develop and manufacture three piece, preservative-free multi-dose and blow-fill-seal packaging of single-use and multi-use eye drop dispensers, which suits Skye’s needs.
七月 21, 2022阅读更多
新闻Nextpharma Technologies USA Inc acquired Santen Pharmaceutical Co. on Jan 1st '19.Recently, in January 2019, NextPharma acquired Santen SA, a contract manufacturing organization, for expansion of its manufacturing facility.
七月 30, 2021阅读更多
查看 NextPharma 的所有信号
让您的销售团队专注于最有希望的机会。通过分清机会的轻重缓急并在合适的时机介入,您可以优化工作并达成更多交易。